Biotech Stocks
Novo aims to diversify with new pipeline assets and bolt-on deals
Endpoints News
1h ago
Fresh from its rebrand last week, Novo CEO Maziar Mike Doustdar spelled out on Monday the strategic vision that goes along with it. At the Danish drugmaker capital markets day in London ...
Discussion
Sign in to join the discussion. Comments loading…